Works matching IS 00126667 AND DT 2021 AND VI 81 AND IP 17


Results: 11
    1
    2
    3
    4

    Mobocertinib: First Approval.

    Published in:
    Drugs, 2021, v. 81, n. 17, p. 2069, doi. 10.1007/s40265-021-01632-9
    By:
    • Markham, Anthony
    Publication type:
    Article
    5
    6
    7

    Vosoritide: First Approval.

    Published in:
    Drugs, 2021, v. 81, n. 17, p. 2057, doi. 10.1007/s40265-021-01623-w
    By:
    • Duggan, Sean
    Publication type:
    Article
    8

    Zimberelimab: First Approval.

    Published in:
    Drugs, 2021, v. 81, n. 17, p. 2063, doi. 10.1007/s40265-021-01628-5
    By:
    • Markham, Anthony
    Publication type:
    Article
    9

    Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2).

    Published in:
    Drugs, 2021, v. 81, n. 17, p. 2017, doi. 10.1007/s40265-021-01624-9
    By:
    • Bacharach, Jason;
    • Tatham, Andrew;
    • Ferguson, Gloria;
    • Belalcázar, Sandra;
    • Thieme, Hagen;
    • Goodkin, Margot L.;
    • Chen, Michelle Y.;
    • Guo, Qiang;
    • Liu, Jeen;
    • Robinson, Michael R.;
    • Bejanian, Marina;
    • Wirta, David L.;
    • the ARTEMIS 2 Study Group;
    • Alezzandrini, Arturo;
    • Bercovich, Gabriel;
    • Deromedis, Pablo;
    • Furno Sola, Federico;
    • Gentile, Carolina;
    • Lerner, Simon;
    • Lupinacci, Anahi
    Publication type:
    Article
    10
    11